GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Land And Improvements

NuCana (NuCana) Land And Improvements : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NuCana Land And Improvements?

NuCana's land and improvements for the quarter that ended in Mar. 2024 was $0.00 Mil.


NuCana Land And Improvements Historical Data

The historical data trend for NuCana's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Land And Improvements Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Land And Improvements
Get a 7-Day Free Trial Premium Member Only - - - - -

NuCana Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NuCana Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


NuCana (NuCana) Business Description

Traded in Other Exchanges
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

NuCana (NuCana) Headlines

From GuruFocus

NuCana Announces Receipt of NASDAQ Notice

By GuruFocusNews GuruFocusNews 06-13-2022

NuCana Announces Receipt of NASDAQ Notice

By GuruFocusNews GuruFocusNews 07-03-2022

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

By Stock market mentor Stock market mentor 01-23-2023

NuCana to Present at the Jefferies London Healthcare Conference

By Value_Insider Value_Insider 11-08-2022

NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference

By Stock market mentor Stock market mentor 01-03-2023

NuCana to Participate in Two Upcoming Investor Conferences

By sperokesalga sperokesalga 02-28-2023